Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 2
1965 5
1966 5
1967 3
1968 2
1969 2
1970 1
1971 4
1972 12
1973 5
1974 1
1975 4
1976 3
1977 4
1978 5
1979 7
1980 3
1981 3
1982 9
1983 3
1984 6
1985 6
1986 7
1987 15
1988 11
1989 7
1990 7
1991 10
1992 8
1993 15
1994 29
1995 22
1996 22
1997 22
1998 18
1999 18
2000 8
2001 14
2002 13
2003 15
2004 16
2005 16
2006 11
2007 14
2008 18
2009 15
2010 25
2011 21
2012 25
2013 21
2014 19
2015 21
2016 31
2017 30
2018 27
2019 25
2020 22
2021 20
2022 19
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

723 results

Results by year

Filters applied: . Clear all
Page 1
Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa.
Hirami Y, Mandai M, Sugita S, Maeda A, Maeda T, Yamamoto M, Uyama H, Yokota S, Fujihara M, Igeta M, Daimon T, Fujita K, Ito T, Shibatani N, Morinaga C, Hayama T, Nakamura A, Ueyama K, Ono K, Ohara H, Fujiwara M, Yamasaki S, Watari K, Bando K, Kawabe K, Ikeda A, Kimura T, Kuwahara A, Takahashi M, Kurimoto Y. Hirami Y, et al. Among authors: kawabe k. Cell Stem Cell. 2023 Dec 7;30(12):1585-1596.e6. doi: 10.1016/j.stem.2023.11.004. Cell Stem Cell. 2023. PMID: 38065067
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: kawabe k. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
Point absorbers in Advanced LIGO.
Brooks AF, Vajente G, Yamamoto H, Abbott R, Adams C, Adhikari RX, Ananyeva A, Appert S, Arai K, Areeda JS, Asali Y, Aston SM, Austin C, Baer AM, Ball M, Ballmer SW, Banagiri S, Barker D, Barsotti L, Bartlett J, Berger BK, Betzwieser J, Bhattacharjee D, Billingsley G, Biscans S, Blair CD, Blair RM, Bode N, Booker P, Bork R, Bramley A, Brown DD, Buikema A, Cahillane C, Cannon KC, Cao HT, Chen X, Ciobanu AA, Clara F, Compton C, Cooper SJ, Corley KR, Countryman ST, Covas PB, Coyne DC, Datrier LE, Davis D, Difronzo CD, Dooley KL, Driggers JC, Dupej P, Dwyer SE, Effler A, Etzel T, Evans M, Evans TM, Feicht J, Fernandez-Galiana A, Fritschel P, Frolov VV, Fulda P, Fyffe M, Giaime JA, Giardina DD, Godwin P, Goetz E, Gras S, Gray C, Gray R, Green AC, Gupta A, Gustafson EK, Gustafson D, Hall E, Hanks J, Hanson J, Hardwick T, Hasskew RK, Heintze MC, Helmling-Cornell AF, Holland NA, Izmui K, Jia W, Jones JD, Kandhasamy S, Karki S, Kasprzack M, Kawabe K, Kijbunchoo N, King PJ, Kissel JS, Kumar R, Landry M, Lane BB, Lantz B, Laxen M, Lecoeuche YK, Leviton J, Jian L, Lormand M, Lundgren AP, Macas R, Macinnis M, Macleod DM, Mansell GL, Marka S, Marka Z, Martynov DV, Mason K, Massinger TJ, M… See abstract for full author list ➔ Brooks AF, et al. Among authors: kawabe k. Appl Opt. 2021 May 1;60(13):4047-4063. doi: 10.1364/AO.419689. Appl Opt. 2021. PMID: 33983346
Familial pancreatic cancer: Concept, management and issues.
Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Matsubayashi H, et al. Among authors: kawabe k. World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. World J Gastroenterol. 2017. PMID: 28246467 Free PMC article. Review.
Overview of green tea interaction with cardiovascular drugs.
Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, Myasoedova V, Takeuchi K, Adachi E, Inui N, Tremoli E, Watanabe H. Werba JP, et al. Among authors: kawabe k. Curr Pharm Des. 2015;21(9):1213-9. doi: 10.2174/1381612820666141013135045. Curr Pharm Des. 2015. PMID: 25312732 Review.
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y. Murakami M, et al. Among authors: kawabe k. J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26. J Gastroenterol. 2023. PMID: 37099152
Tests of General Relativity with GW170817.
Abbott BP, Abbott R, Abbott TD, Acernese F, Ackley K, Adams C, Adams T, Addesso P, Adhikari RX, Adya VB, Affeldt C, Agarwal B, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Allen B, Allen G, Allocca A, Aloy MA, Altin PA, Amato A, Ananyeva A, Anderson SB, Anderson WG, Angelova SV, Antier S, Appert S, Arai K, Araya MC, Areeda JS, Arène M, Arnaud N, Arun KG, Ascenzi S, Ashton G, Ast M, Aston SM, Astone P, Atallah DV, Aubin F, Aufmuth P, Aulbert C, AultONeal K, Austin C, Avila-Alvarez A, Babak S, Bacon P, Badaracco F, Bader MKM, Bae S, Baker PT, Baldaccini F, Ballardin G, Ballmer SW, Banagiri S, Barayoga JC, Barclay SE, Barish BC, Barker D, Barkett K, Barnum S, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Bartos I, Bassiri R, Basti A, Batch JC, Bawaj M, Bayley JC, Bazzan M, Bécsy B, Beer C, Bejger M, Belahcene I, Bell AS, Beniwal D, Bensch M, Berger BK, Bergmann G, Bernuzzi S, Bero JJ, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Bhandare R, Bilenko IA, Bilgili SA, Billingsley G, Billman CR, Birch J, Birney R, Birnholtz O, Biscans S, Biscoveanu S, Bisht A, Bitossi M, Bizouard MA, Blackburn JK, Blackman J, Blair CD, Blair DG, Blair RM… See abstract for full author list ➔ Abbott BP, et al. Among authors: kawabe k. Phys Rev Lett. 2019 Jul 3;123(1):011102. doi: 10.1103/PhysRevLett.123.011102. Phys Rev Lett. 2019. PMID: 31386391 Free article.
[Indigocarmine test].
Kawabe K. Kawabe K. Nihon Rinsho. 1997 Apr;55 Suppl 2:608-9. Nihon Rinsho. 1997. PMID: 9172602 Review. Japanese. No abstract available.
RUNX2 Promotes Malignant Progression in Glioma.
Yamada D, Fujikawa K, Kawabe K, Furuta T, Nakada M, Takarada T. Yamada D, et al. Among authors: kawabe k. Neurochem Res. 2018 Nov;43(11):2047-2054. doi: 10.1007/s11064-018-2626-4. Epub 2018 Sep 10. Neurochem Res. 2018. PMID: 30203400
723 results